Quality of Life in Thyroid Cancer is Similar to That of Other Cancers with Worse Survival

World Journal of Surgery

Volumn 40, Issue 3, 2016, Pages 551-561

  Applewhite, Megan K ^a   James, Benjamin C ^a   Kaplan, Sharone P ^a   Angelos, Peter ^a   Kaplan, Edwin L ^a   Grogan, Raymon H ^a   Aschebrook Kilfoy, Briseis ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH; HUMAN; INCIDENCE; NEOPLASMS; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; SURVIVAL RATE; SURVIVOR; THYROID NEOPLASMS; TRENDS;

GLOBAL HEALTH; HUMANS; INCIDENCE; NEOPLASMS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; SURVIVAL RATE; SURVIVORS; THYROID NEOPLASMS;

EID: 84957431021     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-015-3300-5     Document Type: Article

References (27)

1. Cella D, Stone AA (2015) Health-related quality of life measurement in oncology: advances and opportunities. Am Psychol 70(2):175-185
2. Cella DF (1994) Quality of life: concepts and definition. J Pain Symptom Manage 9(3):186-192
3. Brady MJ et al (1999) A case for including spirituality in quality of life measurement in oncology. Psychooncology 8(5):417-428
4. Aschebrook-Kilfoy B et al (2015) Risk factors for decreased quality of life in thyroid cancer survivors: initial findings from the North American Thyroid Cancer Survivorship Study. Thyroid. doi: 10.1089/thy.2015.0098
5. Duan H et al (2015) Quality of life aspects in the management of thyroid cancer. Oral Oncol 51(6):S1-S5
6. Dow KH, Ferrell BR, Anello C (1997) Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 7(4):613-619
7. Roberts KJ, Lepore SJ, Urken ML (2008) Quality of life after thyroid cancer: an assessment of patient needs and preferences for information and support. J Cancer Educ 23(3):186-191
8. Mendoza A et al (2004) Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction. Thyroid 14(2):133-140
9. Kilfoy BA et al (2009) International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 20(5):525-531
10. Tan LG et al (2007) Health-related quality of life in thyroid cancer survivors. Laryngoscope 117(3):507-510
11. Crevenna R et al (2003) Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Support Care Cancer 11(9):597-603
12. Hoftijzer HC et al (2008) Quality of life in cured patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93(1):200-203
13. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5-29
14. Ferrell BR. Quality of life: thyroid version. 2000. http://prc.coh.org/pdf/Thyroid%20QOL.pdf
15. Sun V et al (2012) Quality of life and barriers to symptom management in colon cancer. Eur J Oncol Nurs 16(3):276-280
16. Munoz C et al (2008) The quality of life of patients with malignant gliomas and their caregivers. Soc Work Health Care 47(4):455-478
17. Dow KH et al (1996) An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat 39(3):261-273
18. Nazik E, Ozdemir F, Soydan S (2014) Social support and quality of life in Turkish patients with gynecologic cancer. Asian Pac J Cancer Prev 15(7):3081-3086
19. Aschebrook-Kilfoy B et al (2013) The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Ann Surg Oncol 20(8):2746-2753
20. Lee JI et al (2010) Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea. Health Qual Life Outcomes 8:101
21. Gamper EM et al. (2015) Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme. Eur J Nucl Med Mol Imaging 42(8):1179-1188
22. Tagay S et al (2005) Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment. Eur J Endocrinol 153(6):755-763
23. Schoormans D et al (2015) The impact of co-morbidity on health-related quality of life in breast cancer survivors and controls. Acta Oncol 54(5):727-734
24. Aschebrook-Kilfoy B et al (2013) The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev 22(7):1252-1259
25. Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351(9114):1451-1467
26. Vogel CL et al (2002) Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20(3):719-726
27. Ashing-Giwa K, Ganz PA, Petersen L (1999) Quality of life of African-American and white long term breast carcinoma survivors. Cancer 85(2):418-426